{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:34:36Z","timestamp":1795080876948,"version":"4.10.2"},"reference-count":25,"publisher":"SAGE Publications","issue":"1S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatitis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1097\/der.0000000000000770","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T17:00:05Z","timestamp":1624813205000},"page":"S39-S44","source":"Crossref","is-referenced-by-count":17,"title":["Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies"],"prefix":"10.1177","volume":"32","author":[{"given":"Brian S.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"DiBonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Kerkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem A.","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"issue":"3","key":"bib1-20221027","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"bib2-20221027","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jdv.15919","article-title":"Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation","volume":"34","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"bib3-20221027","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archdermatol.2011.178","article-title":"The impact of pruritus on quality of life: the skin equivalent of pain","volume":"147","year":"2011","journal-title":"Arch Dermatol"},{"issue":"6","key":"bib4-20221027","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2340\/00015555-1159","article-title":"Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study","volume":"91","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"17","key":"bib5-20221027","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","article-title":"Clinical practice. Chronic pruritus","volume":"368","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"bib6-20221027","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2018.04.044","article-title":"Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial","volume":"79","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"bib7-20221027","first-page":"CD007770","article-title":"Oral H1 antihistamines as monotherapy for eczema","volume":"2013","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"bib8-20221027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.det.2017.02.008","article-title":"Special considerations for therapy of pediatric atopic dermatitis","volume":"35","year":"2017","journal-title":"Dermatol Clin"},{"issue":"6","key":"bib9-20221027","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamadermatol.2020.0796","article-title":"Systemic immunomodulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis","volume":"156","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"bib10-20221027","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","year":"2017","journal-title":"Cell"},{"issue":"2","key":"bib11-20221027","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell\u2013derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","year":"2013","journal-title":"Cell"},{"issue":"1","key":"bib12-20221027","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","year":"2009","journal-title":"Immunol Rev"},{"issue":"3","key":"bib13-20221027","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-015-8488-5","article-title":"Mediators of chronic pruritus in atopic dermatitis: getting the itch out?","volume":"51","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"bib14-20221027","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","year":"2001","journal-title":"Exp Dermatol"},{"key":"bib15-20221027","article-title":"Impact of oral abrocitinib monotherapy on patient-reported symptoms and quality of life in adolescents and adults with moderate-to-severe atopic dermatitis: a pooled analysis of patient-reported outcomes","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"bib16-20221027","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jamadermatol.2019.2855","article-title":"Efficacy and safety of oral Janus kinase 1 inhibitor abrocitinib for patients with atopic dermatitis: a phase 2 randomized clinical trial","volume":"155","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"8","key":"bib17-20221027","first-page":"1","article-title":"Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis (AD): results from the phase 3 JADE MONO-2 study","volume":"156","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"10246","key":"bib18-20221027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(20)30732-7","article-title":"Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"bib19-20221027","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.17744","article-title":"Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis","volume":"181","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"bib20-20221027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis","volume":"186","year":"1993","journal-title":"Dermatology"},{"issue":"3","key":"bib21-20221027","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"bib23-20221027","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jamadermatol.2019.2804","article-title":"Treatment of refractory chronic pruritus of unknown origin with tofacitinib in patients with rheumatoid arthritis","volume":"155","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"bib24-20221027","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nn.3619","article-title":"Why we scratch an itch: the molecules, cells and circuits of itch","volume":"17","year":"2014","journal-title":"Nat Neurosci"},{"issue":"2","key":"bib25-20221027","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jdv.15973","article-title":"Neuroimmune interactions in chronic itch of atopic dermatitis","volume":"34","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"24","key":"bib26-20221027","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DER.0000000000000770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:39Z","timestamp":1777399539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":25,"journal-issue":{"issue":"1S","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000770","relation":{},"ISSN":["2162-5220","1710-3568"],"issn-type":[{"value":"2162-5220","type":"electronic"},{"value":"1710-3568","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,7]]}}}